Back to company

PHARMAORIGIN ApS: Financial statements 2019

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 18,000 compared with DKK -23,000 the year before. Equity amounted to DKK 1,095,000. The solvency ratio was 100%.

Profit/Loss
18,000 kr.
Equity
1,095,000 kr.
Total Assets
1,095,000 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--18 t.1.1 mio.0
2018---23 t.1.1 mio.-
2017---4.3 mio.1.1 mio.-
2016---1.7 mio.5.4 mio.-
2015---135 t.4.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

PHARMAORIGIN ApS: The 2018 annual report is outMay 31, 2019

PHARMAORIGIN ApS has published its annual report for 2018. The net result was DKK -23,000.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.